Dashboard
Manage Tickers

ARGX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-argenx-raises-price-target-to-925
JP Morgan Maintains Overweight on argenx, ...
11/07/2025 19:39:55

JP Morgan analyst James Gordon maintains argenx (NASDAQ:ARGX) with a Overweight and raises the price target from $830 to $925.

heres-how-much-you-would-have-made-owning-argenx-stock-in-the-last-5-years
Here's How Much You Would Have Made Owning...
11/05/2025 15:00:53

argenx-receives-health-canada-approval-for-vyvgart-sc-as-monotherapy-in-adults-with-active-chronic-inflammatory-demyelinating-polyneuropathy
argenx Receives Health Canada Approval For...
11/05/2025 14:54:54

VYVGART® SC is first and only neonatal Fc receptor blocker approved to treat CIDPAuthorization is based on global ADHERE study,...

piper-sandler-maintains-overweight-on-argenx-raises-price-target-to-930
Piper Sandler Maintains Overweight on arge...
11/04/2025 16:37:41

Piper Sandler analyst Allison Bratzel maintains argenx (NASDAQ:ARGX) with a Overweight and raises the price target from $820...

td-cowen-maintains-buy-on-argenx-raises-price-target-to-1146
TD Cowen Maintains Buy on argenx, Raises P...
10/31/2025 16:32:21

TD Cowen analyst Yaron Werber maintains argenx (NASDAQ:ARGX) with a Buy and raises the price target from $800 to $1146.

rbc-capital-maintains-outperform-on-argenx-raises-price-target-to-860
RBC Capital Maintains Outperform on argenx...
10/31/2025 15:17:53

RBC Capital analyst Luca Issi maintains argenx (NASDAQ:ARGX) with a Outperform and raises the price target from $850 to $860.

evercore-isi-group-maintains-outperform-on-argenx-raises-price-target-to-910
Evercore ISI Group Maintains Outperform on...
10/31/2025 13:06:32

Evercore ISI Group analyst Gavin Clark-Gartner maintains argenx (NASDAQ:ARGX) with a Outperform and raises the price target ...

hc-wainwright--co-maintains-buy-on-argenx-raises-price-target-to-915
HC Wainwright & Co. Maintains Buy on argen...
10/31/2025 10:18:54

HC Wainwright & Co. analyst Douglas Tsao maintains argenx (NASDAQ:ARGX) with a Buy and raises the price target from $774...

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

argenx-q3-eps-518-beats-430-estimate-sales-1151b-beat-1056b-estimate
argenx Q3 EPS $5.18 Beats $4.30 Estimate, ...
10/30/2025 06:03:11

argenx (NASDAQ:ARGX) reported quarterly earnings of $5.18 per share which beat the analyst consensus estimate of $4.30 by 20.44...

argenx-to-present-new-data-highlighting-efficacy-and-safety-of-vyvgart-across-gmg-patient-populations-at-2025-aanem-and-mgfa-scientific-session
argenx To Present New Data Highlighting Ef...
10/29/2025 15:05:34

argenx SE ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from...

if-you-invested-1000-in-argenx-stock-5-years-ago-you-would-have-this-much-today
If You Invested $1000 In argenx Stock 5 Ye...
10/22/2025 21:30:57

argenx-to-present-vyvgart-and-empasiprubart-data-at-aanem-annual-meeting-and-mgfa-scientific-session-in-san-francisco
Argenx To Present VYVGART And Empasiprubar...
10/15/2025 05:11:31

Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART's potential to treat broad set of myasthenia gravis ...

how-do-investors-really-feel-about-argenx-se
How Do Investors Really Feel About argenx SE?
10/13/2025 18:00:52

assessing-argenx-insights-from-12-financial-analysts
Assessing argenx: Insights From 12 Financi...
10/13/2025 14:01:00

tesla-to-300-here-are-10-top-analyst-forecasts-for-monday
Tesla To $300? Here Are 10 Top Analyst For...
10/13/2025 13:43:21

wedbush-maintains-outperform-on-argenx-raises-price-target-to-880
Wedbush Maintains Outperform on argenx, Ra...
10/13/2025 13:04:40

Wedbush analyst David Nierengarten maintains argenx (NASDAQ:ARGX) with a Outperform and raises the price target from $800 to...

morgan-stanley-maintains-overweight-on-argenx-raises-price-target-to-1040
Morgan Stanley Maintains Overweight on arg...
10/01/2025 16:13:30

Morgan Stanley analyst Matthew Harrison maintains argenx (NASDAQ:ARGX) with a Overweight and raises the price target from $7...

heres-how-much-100-invested-in-argenx-5-years-ago-would-be-worth-today
Here's How Much $100 Invested In argenx 5 ...
09/29/2025 14:31:48

argenx (NASDAQ: ARGX) has outperformed the market over the past 5 years by 7.61% on an annualized basis producing an average an...

price-over-earnings-overview-argenx
Price Over Earnings Overview: argenx
09/26/2025 21:00:29

In the current market session, argenx Inc. (NASDAQ: ARGX) share price is at $711.62, after a 0.07% increase. Moreover, over the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION